Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,648.16
(
0.19%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 188045

Monday, 05/04/2015 9:47:04 AM

Monday, May 04, 2015 9:47:04 AM

Post# of 257267
Class-action suit filed against RVNC with respect to the company’s non-statements regarding formulation issues with RT001 (the topical botulinum-toxin product):

http://www.sec.gov/Archives/edgar/data/1479290/000119312515167699/d918520d8k.htm

As previously posted, if the decision were up to me, I would would drop RT001 and focus entirely on RT002, the injected botulinum-toxin product that RVNC claims is superior to Botox.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today